Fieldpoint Private Securities, LLC United Therapeutics Corp Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 55 shares of UTHR stock, worth $19,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 190
71.05%
Holding current value
$19,860
Previous $34,000
61.76%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding UTHR
# of Institutions
723Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$6.61 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.6 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$997 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$890 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...